###begin article-title 0
Ligation of alpha-Dystroglycan on Podocytes Induces Intracellular Signaling: A New Mechanism for Podocyte Effacement?
###end article-title 0
###begin p 1
Conceived and designed the experiments: NPV HJV MAHBvB JB JvdV. Performed the experiments: NPV HJV MAHBvB JvdV. Analyzed the data: NPV HJV MAHBvB JB JvdV. Contributed reagents/materials/analysis tools: NPV HJV MAHBvB JB JvdV. Wrote the paper: NPV HJV MAHBvB JB JvdV.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
alpha-Dystroglycan is a negatively charged glycoprotein that covers the apical and basolateral membrane of the podocyte. Its transmembrane binding to the cytoskeleton is regulated via tyrosine phosphorylation (pY892) of beta-dystroglycan. At the basolateral side alpha-dystroglycan binds the glomerular basement membrane. At the apical membrane, it plays a role in the maintenance of the filtration slit. In this study, we evaluated whether ligation of alpha-dystroglycan with specific antibodies or natural ligands induces intracellular signaling, and whether there is an effect on podocyte architecture.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 50 58 50 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
Conditionally immortalized podocytes were exposed in vitro to antibodies to alpha-dystroglycan, and to fibronectin, biglycan, laminin and agrin. Intracellular calcium fluxes, phosphorylation of beta-dystroglycan and podocyte architecture were studied. Antibodies to alpha-dystroglycan could specifically induce calcium signaling. Fibronectin also induced calcium signaling, and led to dephosphorylation of pY892 in beta-dystroglycan. Ligation of alpha-dystroglycan resulted in an altered actin architecture, a decreased number of podocyte pedicles and a more flattened appearance of the podocyte.
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
We conclude that ligation of alpha-dystroglycan on podocytes induces intracellular calcium signaling, which leads to an altered cytoskeleton architecture akin to the situation of foot process effacement. In particular the ability of fibronectin to induce intracellular signaling events is of interest, since the expression and excretion of this protein is upregulated in several proteinuric diseases. Therefore, fibronectin-induced signaling via dystroglycan may be a novel mechanism for foot process effacement in proteinuric diseases.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 129 132 129 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Pavenstadt1">[1]</xref>
Podocytes are highly specialized glomerular visceral epithelial cells that cover the outside of the glomerular basement membrane [1]. Podocytes together with the glomerular basement membrane and the glomerular endothelium constitute the size and charge selective filter of the glomerulus. The podocyte cell body forms primary and secondary extensions, which form foot processes that interdigitate with those of neighboring podocytes and that are attached to each other by the slit diaphragm. In many glomerular diseases with proteinuria, podocyte foot processes are effaced, as their extensions are lost.
###end p 9
###begin p 10
###xml 125 128 125 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-IbraghimovBeskrovnaya1">[2]</xref>
###xml 130 133 130 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Hoffman1">[3]</xref>
###xml 209 212 209 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Durbeej1">[4]</xref>
###xml 214 217 214 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Durbeej2">[5]</xref>
###xml 335 338 335 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Raats1">[6]</xref>
###xml 340 343 340 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Vogtlander1">[7]</xref>
###xml 376 380 376 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DAG1</italic>
###xml 573 576 566 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-IbraghimovBeskrovnaya1">[2]</xref>
###xml 938 941 924 927 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Raats1">[6]</xref>
###xml 943 946 929 932 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Ervasti1">[8]</xref>
###xml 948 951 934 937 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Regele1">[9]</xref>
###xml 1265 1268 1247 1250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Vogtlander1">[7]</xref>
###xml 1360 1363 1338 1341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Ervasti1">[8]</xref>
###xml 1510 1514 1484 1488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Vogtlander2">[10]</xref>
Dystroglycan was identified as a component of the dystrophin glycoprotein complex, which is involved in muscular dystrophies [2], [3]. Thereafter, dystroglycan was described as a component in epithelial cells [4], [5], and we have shown that dystroglycan is expressed by podocytes, both at the basolateral and the apical cell membrane [6], [7]. The dystroglycan encoding gene DAG1 was first cloned and sequenced in 1992. Dystroglycan is post-translationally cleaved into the extracellular alpha subunit and the integral membrane beta subunit, which non-covalently interact [2]. Dystroglycan provides a link between the extracellular matrix like the glomerular basement membrane to the actin cytoskeleton of the podocyte. alpha- Dystroglycan binds to laminin G modules that are present in laminin and agrin, whereas beta-dystroglycan is connected to the actin cytoskeleton via dystrophin or its ubiquitous homologue utrophin in the kidney [6], [8], [9]. alpha-Dystroglycan undergoes massive O-mannosyl glycosilation with terminal sialic acids, which serve by virtue of their negative charge as an anti-adhesion layer on the apical podocyte membrane, analogous to podocalyxin, a sialic acid-rich glycoprotein that also covers the apical cell membrane of the podocyte [7]. The glycosilation of alpha-dystroglycan is necessary for its binding to laminin G modules [8]. We have shown previously that deglycosilation of alpha-dystroglycan by reactive oxygen species results in a loss of binding to agrin and laminin [10].
###end p 10
###begin p 11
###xml 144 148 140 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Bowe1">[11]</xref>
###xml 485 489 481 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Schaefer1">[12]</xref>
###xml 490 494 486 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Schaefer2">[16]</xref>
###xml 638 642 631 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Okuda1">[17]</xref>
###xml 754 758 744 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Stokes1">[13]</xref>
###xml 879 883 869 873 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-BjornsonGranqvist1">[18]</xref>
###xml 885 889 875 879 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Kuroda2">[19]</xref>
###xml 968 972 958 962 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Kuroda1">[15]</xref>
###xml 440 445 <span type="species:ncbi:9606">human</span>
###xml 634 637 <span type="species:ncbi:10116">rat</span>
###xml 934 942 <span type="species:ncbi:9606">patients</span>
The small leucine-rich repeat at the C-terminal tail of alpha-dystroglycan has been shown to bind to chondroitin sulfate A and/or C on biglycan [11]. Biglycan is a small leucine-rich proteoglycan with chondroitin sulfate or dermatan sulfate side chains. It has been shown to be predominantly localized in the tubular interstitium and intrarenal arteries. Minimal expression of biglycan in the mesangial matrix has been described for normal human kidney and various glomerular diseases [12]-[16]. TGF-beta-mediated mesangial upregulation of biglycan has been described in Thy-1 mediated membranoproliferative glomerulonephritis in the rat [17]. TGF-beta induces fibrosis and as a consequence it is especially co-localized with collagen type I in fibrosis [13].The assembly of chondroitin sulfate side chains decreases after exposure to puromycin-aminonucleoside and dexamethasone [18], [19]. Biglycan is not detectable in the urine of patients with glomerular diseases [15].
###end p 11
###begin p 12
###xml 122 126 118 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Hall1">[20]</xref>
###xml 499 503 495 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Kubosawa1">[21]</xref>
###xml 504 508 500 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Cohen1">[24]</xref>
###xml 751 755 747 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Soylemezoglu1">[25]</xref>
###xml 756 760 752 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-KilisPstrusinska1">[27]</xref>
It was recently shown that the C-terminal domain of muscle alpha-dystroglycan can also bind to fibronectin and fibrinogen [20]. Fibronectin is a 500 kDa protein that consists of two similar 250 kDa subunits linked via a disulfide bond. By post-translational processing plasma and tissue isoforms are formed. An increased expression of both plasma and tissue fibronectin has been documented in various glomerular diseases like diabetic nephropathy, puromycin-aminonucleoside and adriamycin nephrosis [21]-[24]. Furthermore, urinary excretion of fibronectin has been shown to correlate with proteinuria in IgA-nephropathy, membranous glomerulopathy, and diabetic nephropathy and with glomerulosclerosis in lupus nephritis and chronic glomerulonephritis [25]-[27].
###end p 12
###begin p 13
###xml 160 164 153 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Jung1">[28]</xref>
###xml 165 169 158 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-James1">[30]</xref>
###xml 347 351 337 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Jung1">[28]</xref>
###xml 352 356 342 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-James1">[30]</xref>
###xml 479 483 469 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Macias1">[31]</xref>
###xml 651 655 638 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Rentschler1">[29]</xref>
###xml 657 661 644 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Huang1">[32]</xref>
###xml 770 774 754 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-James1">[30]</xref>
###xml 776 780 760 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Ilsley1">[33]</xref>
###xml 963 967 944 948 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Sotgia1">[34]</xref>
###xml 969 973 950 954 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Yang1">[35]</xref>
The extracellular N-terminal domain of beta-dystroglycan interacts with alpha-dystroglycan, whereas the intracellular C-terminal domain interacts with utrophin [28]-[30]. In particular, a PPxY motif including a tyrosine residue at position 892 in beta-dystroglycan in the C-terminal domain is necessary for interaction with WW domains in utrophin [28]-[30]. WW domains are 30-40 amino acid motifs containing two conserved tryptophan residues, that bind to proline-rich sequences [31]. The interaction of beta-dystroglycan with dystrophin/utrophin is stabilized by a helix-turn-helix motif, i.e. EF hand, close to the PPxY motif in dystrophin/utrophin [29], [32]. Furthermore, dephosphorylation of Y892 (pY892) in beta-dystroglycan enables binding to utrophin/dystrophin [30], [33]. Phosphorylation of beta-dystroglycan enhances recruitment of SH2/SH3 domain containing proteins like c-Src, Fyn, Csk, NCK, SHC and Grb-2, which all are involved in signaling events [34], [35]. This suggests a role for dystroglycan in signaling.
###end p 13
###begin p 14
In this study, we investigated whether ligation of alpha-dystroglycan by monoclonal antibodies against alpha-dystroglycan and natural ligands for alpha-dystroglycan, such as laminin, agrin, biglycan and fibronectin, leads to intracellular signaling as assessed by measuring calcium fluxes and to changes in the phosphorylation status of beta-dystroglycan at position 892 (Y892). In addition, we investigated whether alpha-dystroglycan ligation had an impact on actin cytoskeleton architecture and podocyte morphology.
###end p 14
###begin title 15
Results
###end title 15
###begin p 16
###xml 480 483 468 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Durbeej1">[4]</xref>
###xml 485 489 473 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Matsumura1">[36]</xref>
###xml 641 650 629 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005979-g001">Figure 1A</xref>
###xml 1103 1112 1083 1092 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005979-g001">Figure 1B</xref>
###xml 24 29 <span type="species:ncbi:10090">mouse</span>
###xml 1424 1429 <span type="species:ncbi:10090">mouse</span>
The binding of cultured mouse podocytes to EHS laminin, agrin, collagen A and Matrigel coated plates was quantified with the hexosaminidase assay. Podocytes were pre-incubated with alpha-dystroglycan specific antibodies, IIH6 or VIA4.1, directed to carbohydrate epitopes on alpha-dystroglycan, prior to seeding on the coatings. It is known that monoclonal antibody IIH6 inhibits the binding of alpha-dystroglycan to laminin G modules, whereas monoclonal antibody VIA 4.1 does not [4], [36]. Indeed, the number of podocytes binding to laminin decreased after pre-incubation with IIH6, but remained unaltered after pre-incubation with VIA4.1 (Figure 1A). Pre-incubation with isotype controls for either of the alpha-dystroglycan antibodies (TEPC and MOPC respectively) did not affect the binding. As expected, similar results were obtained with agrin as coated ligand (data not shown). However, the binding of podocytes to collagen A, which is comprised of type I collagen that does not contain laminin G modules, was unaltered by the addition of either of the two alpha-dystroglycan specific antibodies (Figure 1B). Furthermore, the binding of podocytes to Matrigel(c) which is considered as a surrogate basement membrane preparation containing a mixture of several extracellular matrix molecules, could not be prevented by MoAb IIH6 (data not shown). Therefore, monoclonal antibody IIH6 specifically inhibits the binding of mouse podocytes to laminin EHS and agrin, indicating an important role for alpha-dystroglycan for the binding of podocytes to laminin G modules containing proteins such as laminin and agrin in the glomerular basement membrane.
###end p 16
###begin title 17
Inhibition of podocyte binding to laminin by anti alpha-dystroglycan monoclonal antibodies IIH6 and VIA 4.1.
###end title 17
###begin p 18
Podocytes were seeded on laminin (A) or collagen A coatings (B) after pre-incubation with either monoclonal antibody IIH6 using TEPC as an isotype control, or with VIA 4.1 using MOPC 21 as an isotype control. Monoclonal antibody IIH6 specifically inhibits podocyte binding to laminin, but not to collagen A.
###end p 18
###begin p 19
###xml 451 463 443 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005979-g002">Figure 2A, B</xref>
###xml 1069 1073 1049 1053 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Vogtlander2">[10]</xref>
###xml 1128 1140 1108 1120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005979-g002">Figure 2C, D</xref>
###xml 1185 1194 1165 1174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005979-g002">Figure 2F</xref>
###xml 1322 1326 1298 1302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Bowe1">[11]</xref>
###xml 1689 1693 1661 1665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Kubosawa1">[21]</xref>
###xml 1694 1698 1666 1670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-KilisPstrusinska1">[27]</xref>
###xml 1850 1851 1818 1819 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1855 1856 1820 1821 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 2206 2207 2160 2161 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 2211 2212 2162 2163 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 2345 2354 2292 2301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005979-g002">Figure 2E</xref>
###xml 2889 2897 2830 2838 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005979-g003">Figure 3</xref>
###xml 3590 3598 3527 3535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005979-g003">Figure 3</xref>
###xml 3732 3736 3669 3673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Sotgia2">[37]</xref>
###xml 3859 3863 3796 3800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Mundel1">[38]</xref>
###xml 3868 3876 3805 3813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005979-g004">figure 4</xref>
###xml 4272 4279 4201 4208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005979-t001">Table 1</xref>
###xml 4407 4415 4336 4344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005979-g004">figure 4</xref>
###xml 48 53 <span type="species:ncbi:10090">mouse</span>
###xml 3099 3103 <span type="species:ncbi:10116">rats</span>
###xml 3108 3112 <span type="species:ncbi:10116">rats</span>
###xml 3443 3447 <span type="species:ncbi:10116">rats</span>
Next, we analyzed whether alpha-dystroglycan on mouse podocytes could mediate outside-in signaling. The ability of monoclonal antibodies IIH6 and VIA 4.1 and their respective isotype controls to induce calcium fluxes was assessed by the fura 2 method, which measures the cytosolic calcium concentration. Both monoclonal antibodies could specifically induce calcium signaling after ligation of alpha-dystroglycan, whereas the isotype controls did not (Figure 2A, B). The peak of the cytosolic calcium concentration was similar in the presence or absence of extracellular calcium, indicating that the cytosolic calcium influx was derived from the intracellular calcium stores. Although these experiments indicate that ligation of alpha-dystroglycan mobilizes intracellular calcium stores, this induction by specific antibodies is however, not a physiological event. Therefore, the ability of natural ligands of alpha-dystroglycan to induce a similar rise in cytosolic calcium was investigated. Both laminin and agrin, which both can bind to glomerular alpha-dystroglycan [10], were not able to induce a rise in cytosolic calcium (Figure 2C, D). Biglycan induced a modest calcium influx (Figure 2F). Since the interaction of biglycan with muscle alpha- dystroglycan depends on the chondroitin sulfate side chains of biglycan [11], we also tested the effect of adding chondroitin sulfate A, B and C, and heparan sulfate. However, both chondroitin sulfate preparations as well as heparan sulfate did not induce calcium mobilization in the cytosol (data not shown). Since fibronectin is a known ligand of muscle alpha-dystroglycan, and a protein which is involved in several glomerular diseases [21]-[27], we evaluated the effect of fibronectin on calcium fluxes. Since we could not rule out that RGD motives in fibronectin could induce signaling via alpha3beta1integrin, these RGD fibronectin receptor recognition sequences in integrins were blocked by pre-incubation with RGD peptide. We included RGD blocking, although alpha3beta1integrins are mainly expressed at the basal and not at the apical side of podocytes. Addition of RGD peptide did not result in calcium fluxes. Fibronectin, after blocking of alpha3beta1integrin with RGD peptides, induced the strongest cytosolic calcium influx of all 4 endogenous ligands of alpha-dystroglycan tested (Figure 2E). This finding indicates that fibronectin can induce calcium fluxes in podocytes, via other molecules than integrins. To further investigate whether the dystroglycan complex is involved in fibronectin-induced calcium fluxes in podocytes, its effect on the phosphorylation state of Y892 in beta-dystroglycan was investigated. It appeared that stimulation of podocytes by fibronectin (concomitantly with blocking with RGD peptide) led to a decrease in phosphorylation of Y892, while the total amount of beta-dystroglycan was unaltered (Figure 3). This latter finding suggests that alpha-dystroglycan is involved in fibronectin-induced calcium influxes in podocytes. We have also studied the expression level of pY892 in renal sections of control rats and rats with adriamycin nephropathy, with normal and effaced podocytes, respectively. We applied several antigen retrieval techniques, and an epitope preservation approach by inclusion of phosphatase inhibitors. However, despite an additional signal amplification, the detectable expression levels of pY892 in both control and adriamycin rats were extremely low and, therefore, not conclusive (data not shown), which seems in contrast to our clear findings with Western blot analysis (Figure 3). However, a similar discrepancy between immunofluorescence and Western blot analysis has been observed on skeletal muscle by others [37]. It has been described that differentiation of conditionally immortalized podocytes induces process (filopodia) formation [38]. In figure 4 we show the effect of the anti-alpha-dystroglycan monoclonal antibodies and fibronectin on the morphology of podocytes and actin cytoskeleton. All ligands induced a retraction of filopodia and a reorganization of the cytoskeleton. Statistical analysis of these effects revealed a significant effect for the anti-alpha-dystroglycan monoclonals IIH6 and VIA 4.1, but only a trend for fibronectin (Table 1). However, in several fibronectin-stimulated cells retraction of filopodia was clearly visible as shown in the lower panels of figure 4. This reorganization of the actin cytoskeleton may be a situation reminiscent of foot process effacement. These data suggest that fibronectin-induced signaling events, mediated by the dystroglycan complex leads to an altered podocyte architecture.
###end p 19
###begin title 20
###xml 27 32 <span type="species:ncbi:10090">mouse</span>
Calcium fluxes in cultured mouse podocytes after ligation of alpha-dystroglycan.
###end title 20
###begin p 21
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse podocytes were differentiated on collagen A coatings for 2 weeks. Intracellular calcium concentrations were monitored by the fura-2 method, with and without extracellular calcium. Both alpha-dystroglycan specific monoclonal antibodies induced calcium fluxes, most likely from intracellular stores. Isotype controls were negative (A, B). The laminin G modules-containing proteins agrin and laminin were unable to induce a calcium influx in podocytes (C, D). From the natural ligands of alpha-dystroglycan tested, fibronectin induced the most pronounced calcium influx. Note that blocking of potential integrin binding sites with a RGD peptide did not influence the fibronectin effect (E). The proteoglycan biglycan induced a modest calcium influx (F).
###end p 21
###begin title 22
###xml 36 41 <span type="species:ncbi:10090">mouse</span>
Fibronectin stimulation of cultured mouse podocytes leads to a decrease of pY892 on beta-dystroglycan.
###end title 22
###begin p 23
###xml 9 14 <span type="species:ncbi:10090">mouse</span>
Cultured mouse podocytes were incubated for 3 minutes with fibronectin after which a decrease of pY892 was found in Western blot analysis of whole podocyte cell lysates (right panel), whereas the total amount of beta-dystroglycan was not affected (left panel). Total beta-dystroglycan was probed with NCL-BDG and pY892 was probed with anti-pY892.
###end p 23
###begin title 24
###xml 73 78 <span type="species:ncbi:10090">mouse</span>
Ligation of alpha-dystroglycan results in a loss of pedicles in cultured mouse podocytes.
###end title 24
###begin p 25
###xml 347 351 347 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-YanagidaAsanuma1">[58]</xref>
###xml 353 357 353 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Asanuma1">[65]</xref>
###xml 461 469 461 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 641 647 641 647 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">versus</italic>
###xml 661 662 659 660 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 696 702 694 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">versus</italic>
###xml 716 717 712 713 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 777 778 771 772 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
Differentiated podocytes on collagen coatings were incubated with either monoclonal antibodies IIH6 or VIA 4.1, their respective isotype controls (TEPC or MOPC) or fibronectin. The podocyte pedicles (arrow) are probed with antibodies against Mena (green, which also localizes along stress fibers and in focal contacts at the tips of stress fibers [58], [65]). The pedicles were lost after 6 hours of incubation with the antibodies. As these pedicles may be the in vitro manifestation of foot processes, their retraction may imply foot process effacement. Percentage of podocytes with smooth surfaces were counted, which yielded for IIH6 60% versus TEPC 30% (chi2 = 20.8, p<0.001), for VIA4.1 51% versus MOPC 28% (chi2 = 9.01, p<0.01) and fibronectin 38% versus control 30% (chi2 = 1.3, p = 0.25). (Red = phalloidin (actin); blue = DAPI (DNA)).
###end p 25
###begin title 26
###xml 84 92 84 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
Percentages of podocytes with smooth, intermediate or filopodia rich surfaces after in vitro ligation with alpha-dystroglycan specific antibodies, fibronectin and their respective controls.
###end title 26
###begin p 27
Smooth 0-0.2 filopodia/5 microm, intermediate 0.2-1 filopodia/5 microm or filopodia rich >/=1 filopodia/5 microm cell border.
###end p 27
###begin p 28
###xml 88 89 86 87 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
Significantly different when comparing frequencies in both columns; IIH6 vs. TEPC183 chi2 = 20.8, p<0.001.
###end p 28
###begin p 29
###xml 21 22 19 20 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 77 78 73 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
VIA4.1 vs. MOPC21 chi2 = 9.01, p<0.01 Fibronectin+(FN+) vs. control (FN-) chi2 = 1.3, p = 0.25.
###end p 29
###begin title 30
Discussion
###end title 30
###begin p 31
###xml 221 222 209 210 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 226 227 211 212 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 800 804 781 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Matsumura1">[36]</xref>
###xml 1067 1070 1048 1051 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Durbeej1">[4]</xref>
###xml 1072 1076 1053 1057 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Matsumura1">[36]</xref>
###xml 1662 1663 1635 1636 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1667 1668 1637 1638 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1694 1702 1664 1672 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
alpha-Dystroglycan is a negatively charged glycoprotein, which covers the apical and basolateral membrane of the podocyte. At the basolateral side alpha-dystroglycan binds laminin G modules in agrin and laminin. The alpha3beta1integrin is also expressed at the basolateral side of podocytes, where it extracellulary binds to laminin, fibronectin and collagen. In this study we investigated the importance of alpha-dystroglycan for the binding of podocytes to laminin, agrin and several other extracellular matrix molecules with a new binding assay. Binding of monoclonal antibody IIH6 but not monoclonal antibody VIA4.1 inhibited the binding of podocytes to laminin and agrin. Our findings with podocytes are similar to the data for the binding of Schwannoma cells to laminin as previously described [36]. This is also underlined by the observation that monoclonal antibody VIA 4.1 did not inhibit the binding/growth of podocytes to collagen nor to laminin and agrin, since the carbohydrates recognized by VIA4.1 are not involved in the binding to laminin G moieties [4], [36]. However, no impairment of binding of podocytes to collagen type I coated plates was observed after incubation with monoclonal antibody IIH6. Furthermore, binding of podocytes to Matrigel-coated plates also could not be inhibited by IIH6, which not unexpectedly suggests that podocytes also can bind to additional molecules without laminin G modules. As over 50% of the binding of podocytes to laminin was lost by the addition of monoclonal antibody IIH6, it can be concluded that for binding to laminin alpha-dystroglycan on podocytes is of equal or even greater importance than alpha3beta1integrins. Therefore, our in vitro findings suggest that alpha-dystroglycan represents an important mechanism for podocytes to anchor to the glomerular basement membrane.
###end p 31
###begin p 32
###xml 147 150 147 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Vogtlander1">[7]</xref>
###xml 721 725 713 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Berridge1">[39]</xref>
###xml 321 326 <span type="species:ncbi:10090">mouse</span>
At the apical domain of the podocyte the assumed function of the dystroglycan complex is maintenance of the filtration slit by its negative charge [7]. In this study, we investigated whether dystroglycan plays a role in outside-inside signaling events. Indeed, we observed a specific cytosolic calcium influx in cultured mouse podocytes after ligation of alpha-dystroglycan by two different anti alpha-dystroglycan antibodies. This rise in the cytosolic calcium concentration comes mainly from the intracellular calcium stores, since it was not dependent on the extracellular calcium concentration. This increase in cytosolic calcium is presumably mediated via inositol-1,4,5 tri-phosphate in the endoplasmatic reticulum [39].
###end p 32
###begin p 33
###xml 741 745 729 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Hall1">[20]</xref>
###xml 949 953 933 937 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Gesemann1">[40]</xref>
###xml 1147 1151 1127 1131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Tisi1">[41]</xref>
###xml 1168 1172 1148 1152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Timpl1">[42]</xref>
###xml 1288 1289 1264 1265 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1293 1294 1266 1267 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1504 1508 1477 1481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Blattner1">[43]</xref>
###xml 1510 1514 1483 1487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Kretzler1">[44]</xref>
###xml 2021 2025 1983 1987 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Hall1">[20]</xref>
###xml 2209 2213 2159 2163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Soylemezoglu1">[25]</xref>
###xml 2214 2218 2164 2168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-KilisPstrusinska1">[27]</xref>
###xml 2302 2306 2252 2256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Kubosawa1">[21]</xref>
###xml 2307 2311 2257 2261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Cohen1">[24]</xref>
Since induction of calcium fluxes by these anti alpha-dystroglycan specific antibodies is not a physiological event, we were interested in the effects of natural ligands of dystroglycan like, laminin, agrin, biglycan and fibronectin. From these ligands fibronectin induced the most pronounced signal, biglycan induced only a weak increase in cytosolic calcium, while agrin and laminin were not able to induce such an effect. This difference may be related to the fact that the function of alpha-dystroglycan on the basal side of the podocyte is different from the function at the apical side. Furthermore, clustering of alpha-dystroglycan can be induced by the antibodies, fibronectin and biglycan, as they may all serve as bivalent ligands [20]. In contrast, agrin and laminin probably serve as monovalent ligands. Tandem LG modules are necessary for alpha-dystroglycan binding. Since agrin contains only 3 LG modules, only one tandem is available [40]. Laminin possesses 5 LG modules which enable the formation of maximally two LG tandems. However, their spatial relationship within the molecule may be to close to cross link alpha-dystroglycan [41], for review see [42]. The fibronectin induced rise in cytosolic calcium can in theory be mediated via many complexes. The integrin alpha3beta1 can bind fibronectin via a RGD module, and is intracellulary linked to integrin linked kinase (ILK) which is involved in regulation of the actin cytoskeleton, morphology and cell survival via signaling events [43], [44]. However, the involvement of integrins in the fibronectin-induced rise in cytosolic calcium was excluded by blocking with an RGD peptide. Furthermore, probing of podocytes with fibronectin induced a dephosphorylation of beta-dystroglycan, which makes a role for alpha-dystroglycan in fibronectin induced signaling likely. Immunoprecipitation studies in our laboratory have indeed showed that glomerular alpha-dystroglycan can bind fibronectin (data not shown), confirming previously published observations [20]. Intact fibronectin chains (approximately250 kDa) can only pass the glomerular basement membrane if proteinuria is present, and indeed urinary fibronectin correlates with proteinuria [25]-[27]. Importantly, tissue fibronectin is upregulated during several glomerular diseases [21]-[24].
###end p 33
###begin p 34
###xml 300 304 297 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Sotgia1">[34]</xref>
###xml 407 411 404 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Sotgia2">[37]</xref>
###xml 543 547 537 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Sotgia2">[37]</xref>
###xml 741 745 732 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Sotgia3">[45]</xref>
###xml 847 851 835 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Yang1">[35]</xref>
###xml 857 860 845 848 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FAK</sup>
###xml 937 941 922 926 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Cavaldesi1">[46]</xref>
###xml 1343 1347 1325 1329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Sadasivam1">[47]</xref>
###xml 1458 1462 1437 1441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Spence1">[48]</xref>
###xml 1541 1542 1516 1517 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 1546 1547 1518 1519 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1666 1670 1635 1639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Ferletta1">[49]</xref>
###xml 1672 1676 1641 1645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Spence2">[50]</xref>
###xml 1951 1955 1917 1921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Kucherenko1">[51]</xref>
###xml 1783 1806 <span type="species:ncbi:7227">drosophila melanogaster</span>
The unraveling of the downstream signaling pathways after dystroglycan ligation in podocytes remains challenging. The PPxY domain of beta-dystroglycan can recruit SH2/SH3 domain-containing proteins like c-Src, Fyn, Csk, NCK, SHC and Grb-2. These interactions are enhanced by phosphorylation of pY892 [34]. From these, c-Src has been shown to be able to phosphorylate Y892 in c-Src overexpressing COS7 cells [37]. Also the expression of pY892 beta-dystroglycan increases in COS7 cells when cultured on coatings of laminin, agrin or fibronectin [37]. Caveolin 1 and 3 co-express with beta-dystroglycan in lipid raft domains, and bind when Y892 is phosphorylated. Caveolin 3 has been shown to inhibit the c-Src induced phosphorylation of Y892. [45]. Furthermore, the proline-rich SH3 region of Grb-2 binds at the C terminal side of beta-dystroglycan [35]. p125FAK has been shown to be linked to Grb-2, but not directly to beta-dystroglycan [46]. Taken together, the dynamic role of beta-dystroglycan in signaling seems to provide docking sites for multiple kinases when phosphorylated, or to provide a stable anchorage to the actin cytoskeleton when dephosphorylated. A similar phenomenon was illustrated by a study in which the Src family kinases were shown to be important for the stability of dystroglycan containing clusters induced by agrin [47]. beta-dystroglycan also is able to bind ezrin, which also affects its interaction with the actin cytoskeleton [48]. Dystroglycan suppresses laminin 1 and -10/11 induced ERK activation via alpha6beta1 integrin and direct linking of beta-dystroglycan to the ERK-MAP kinase pathway has also been described in COS 7 cells [49], [50]. Recently, genetic interaction screens on presumed modifier genes for dystroglycan and dystrophin in many drosophila melanogaster mutants, added even more putative signaling pathways, like the Notch, TGF-beta, EGFR, Semaphorin-Plexin, Frazzled-Netrin and Slit-Robo pathways [51].
###end p 34
###begin p 35
###xml 122 125 119 122 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FAK</sup>
###xml 139 142 <span type="species:ncbi:10116">rat</span>
Unfortunately, in co-immunoprecipitation experiments we could not find any binding of beta-dystroglycan to Src, Grb2, p125FAK and ezrin in rat kidney lysates (data not shown). So the signaling pathways linked to beta-dystroglycan in podocytes remains subject for further investigation.
###end p 35
###begin p 36
###xml 235 239 235 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Hunt1">[52]</xref>
###xml 490 494 490 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Reiser1">[53]</xref>
###xml 496 500 496 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Winn1">[54]</xref>
###xml 926 930 922 926 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Takeda1">[55]</xref>
###xml 1718 1722 1703 1707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Rudiger1">[56]</xref>
###xml 1833 1840 1810 1817 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1934 1938 1907 1911 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Kojima1">[57]</xref>
###xml 1950 1958 1923 1931 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 2000 2007 1973 1980 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 768 772 <span type="species:ncbi:10116">rats</span>
###xml 1499 1504 <span type="species:ncbi:10090">mouse</span>
###xml 1588 1593 <span type="species:ncbi:10090">mouse</span>
Alterations in podocyte shape and function are calcium dependent. This has been shown in the calcium switch model in podocytes, in which 90 minutes removal of extracellular calcium results in an increased paracellular flux of dextrans [52]. Mutations in the canonical transient receptor potential 6 (TRPC6) result in an increased amplitude of the calcium current from the extracellular calcium stores, and eventually leads to a form of autosomal dominant focal segmental glomerulosclerosis [53], [54]. However, the calcium flux induced via alpha-dystroglycan is derived from the intracellular calcium stores, which suggests that TRPC6 is not involved in these events. Furthermore, podocyte shape alterations can be induced by sialidase or puromycin aminonucleoside in rats; dephosphorylation of ezrin linked to podocalyxin via NHERF2 results in dissociation from the actin cytoskeleton and concomitant foot process effacement [55]. The involvement of beta-dystroglycan in fibronectin-induced signaling is shown by the decrease in phosphorylation of Y892, which however enhances binding of the dystroglycan complex to the actin cytoskeleton via utrophin. The impact of this enhanced binding to actin was visualized by changes in podocyte morphology. We observed a reorganization of the actin cytoskeleton after ligation of alpha-dystroglycan, with monoclonal antibodies to alpha-dystroglycan and in a subset of podocytes with fibronectin. This was accompanied by a retraction of branches of cultured mouse podocytes. Similar observations have been made by Rudiger et al. after exposure of mouse podocytes to protamin sulfate, which resulted in instant calcium influxes, and podocyte foot process retraction after 2 hrs [56]. Protamin sulfate inhibits the binding of alpha-dystroglycan to laminin and can also bind alpha-dystroglycan, in vivo injection results in immediate foot process effacement and endocytosis of alpha-dystroglycan [57]. Thus, the in vitro retraction of foot processes may reflect in vivo podocyte foot process effacement.
###end p 36
###begin p 37
In summary, the binding of fibronectin to apical free accessible alpha-dystroglycan leads to signaling events in the podocytes, as indicated by a rise in cytosolic calcium and a dephosphorylation of beta-dystroglycan, enabling utrophin and the actin cytoskeleton to bind and retract the podocyte foot process. This may represent a novel mechanism of podocyte foot process effacement in proteinuric disease.
###end p 37
###begin title 38
Methods
###end title 38
###begin title 39
Cell culture
###end title 39
###begin p 40
###xml 211 214 211 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Vogtlander1">[7]</xref>
###xml 216 220 216 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Mundel1">[38]</xref>
###xml 295 298 291 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Vogtlander1">[7]</xref>
###xml 413 416 409 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Vogtlander1">[7]</xref>
###xml 27 32 <span type="species:ncbi:10090">mouse</span>
Conditionally immortalized mouse podocytes (MPC-5, generously provided by Peter Mundel, Division of Nephrology, Albert Einstein College of Medicine, Bronx, NY, USA) were cultured essentially as described before [7], [38]. MPC-5 express alpha-dystroglycan at their apical and basal cell membrane [7]. Passages 12-17 were used in these experiments. Indirect immunofluorescence was performed as described previously [7].
###end p 40
###begin p 41
###xml 220 224 220 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-YanagidaAsanuma1">[58]</xref>
###xml 344 346 344 346 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
###xml 883 884 859 860 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 102 106 <span type="species:ncbi:9925">goat</span>
###xml 112 117 <span type="species:ncbi:10090">mouse</span>
Anti-Mena antibody (Becton Dickinson, Transduction Laboratories, San Jose, CA, USA) dilution 1:40 and goat anti-mouse IgA FITC (Southern Biotech, Birmingham, Alabama, USA) dilution 1:50 were used to probe the filopodia. [58]. Phalloidin-TRITC (Molecular Probes, Leiden, The Netherlands) dilution 1:150, and DAPI (Molecular Probes) dilution 3*10-5 was used to visualize the actin cytoskeleton and DNA, respectively. Sections were investigated by a Leica DM 4000 B microscope (Leica Microsystems, Rijswijk, the Netherlands). Filopodia count on the cell border was studied as follows: The number of filopodia of 2 microm or longer was counted per 5 microm cell border. Cells were divided into 3 categories: smooth 0-0.2 filopodia/5 microm, intermediate 0.2-1 filopodia/5 microm or filopodia rich >/=1 filopodia/5 microm cell border. The frequencies in the groups were compared using chi2.
###end p 41
###begin p 42
###xml 377 381 369 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Ohlendieck1">[59]</xref>
###xml 615 618 603 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Vogtlander1">[7]</xref>
###xml 620 624 608 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Michele1">[60]</xref>
###xml 599 604 <span type="species:ncbi:10090">mouse</span>
For the investigation of binding, propagated podocytes were seeded overnight on laminin EHS (Campro Scientific; Veenendaal, The Netherlands) or collagen A (Biochrom, Berlin, Germany) coated 96 microwell plates (Costar, Corning Life Sciences, Corning, NY) using 3000 podocytes/well with the addition of 1 microM alpha-dystroglycan specific monoclonal antibodies, IIH6 or VIA4.1 [59], or their respective isotype controls, MOPC 21 or TEPC 183 (Sigma, St Louis, MO). Notably, the glycoepitopes on glomerular alpha-dystroglycan are recognized by the antibodies IIH6 and VIA4.1 and expressed by cultured mouse podocytes [7], [60]. Podocytes were inversely centrifuged at 200 g for 1 minute and carefully rinsed three times with phosphate buffered saline (PBS, Merck, Darmstadt, Germany).
###end p 42
###begin p 43
###xml 194 196 194 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N-</italic>
###xml 224 228 221 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Landegren1">[61]</xref>
###xml 350 352 337 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N-</italic>
###xml 605 606 585 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 630 631 610 611 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
To evaluate the number of podocytes a hexosaminidase essay was performed in which the amount of the house keeping enzyme hexosaminidase is quantified by measuring the digestion of p-nitrophenyl-N-acetyl-beta-D-glucosamidine [61]. In short: podocytes were incubated overnight at 37degreesC with 100 microl 50 mM citrate (Merck), 3.75 mM p-nitrophenyl-N-acetyl-beta-D-glucosamidine (Sigma) and 0.25% Triton x100 (Sigma). Thereafter, the reaction was blocked with a solution containing 50 mM glycine (Sigma) and 5 mM EDTA, pH 10.4, 150 microl/well. Optical density was measured at 405 nm. Two-tailed Student-t test was performed and P</=0.05 was considered significant.
###end p 43
###begin title 44
Measurement of calcium fluxes
###end title 44
###begin p 45
###xml 396 397 390 391 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 408 409 402 403 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1041 1045 1029 1033 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Visch1">[62]</xref>
###xml 719 724 <span type="species:ncbi:42554">tetra</span>
###xml 1323 1326 <span type="species:ncbi:10116">rat</span>
Propagated podocytes were seeded on collagen A coated glass cover slips and differentiated for 3 weeks. Subsequently, cells were loaded with 5 mM fura-2-AM (Molecular Probes) and 0.025% pluronic-F127 (Molecular Probes), added to the medium of differentiated podocytes for 20 minutes at 37degreesC. Subsequently, they were washed and mounted in a bath-chamber in 137 mM NaCl, 3.6 mM KCl, 1 mM CaCl2, 1 mM MgCl2, 5,5 mM D-glucose and 10 mM Hepes-Tris buffer pH 7.4 (Sigma) at 37degreesC and placed under an inverted microscope (Nikon) attached to a videorate confocal microscope (Noran Instruments, Middleton, WI). Calcium-free measurements were performed in the same buffer without calcium and with 2 mM ethylene glycol tetra-acetic acid (EGTA, Sigma) added. The podocytes were excited 15 times/min at 340 and 380 nm, with an exposure time of 100 ms and single cell emission at 492 nm was monitored as a measure of the cytosolic free calcium concentration. Dynamic video imaging was carried out using the MagiCal hardware and Tardis software [62]. The effects of the addition of 1 microM biglycan (Sigma), 1 microM laminin, 1 microM IIH6, 1 microM VIA4.1, 1 microM MOPC 21, 1 microM TEPC 183 (Sigma), 1 microM heparan sulfate (Seikagaku), a mixture of 2 mg/ml chondroitin sulfate A, 1 microM B and C (Sigma), or 0.025 mg/ml rat fibronectin (250 kDa chains, Sigma) on calcium fluxes were evaluated. Only for the measurement of the effect of fibronectin on calcium fluxes, podocytes were prior to the addition of fibronectin maintained in serum-free medium for 24 hrs. Possible fibronectin binding sites on integrins were blocked with GRGDS peptide (160 microM, Sigma).
###end p 45
###begin title 46
Western blot analysis
###end title 46
###begin p 47
###xml 98 102 98 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Vogtlander2">[10]</xref>
###xml 104 108 104 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Laemmli1">[63]</xref>
###xml 422 426 422 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005979-Sharma1">[64]</xref>
###xml 614 617 614 617 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H+L</sub>
###xml 595 599 <span type="species:ncbi:9925">goat</span>
###xml 605 610 <span type="species:ncbi:10090">mouse</span>
Western blot analysis was performed according to the methods of Laemmli and as described recently [10], [63]. Whole podocyte cell lysates were blotted onto nitrocellulose and blocked with 5% non-fat dry milk (Biorad, Veenendaal, the Netherlands) in PBS. Phosphatase inhibitors, 10 mM NaF (Sigma) and 1 mM sodium orthovanadate (Sigma), were added to the buffers used during the whole procedure to prevent dephosphorylation [64]. Anti-pY892 (1:50 BD Biosciences, San Jose, USA) and NCL-BDG (1:10 Novocastra, Newcastle upon Tyne, United Kingdom) were used as primary antibodies. Peroxidase labeled goat anti mouse IgGH+L1:5000, was used as secondary antibody.
###end p 47
###begin p 48
We like to thank Kevin P. Campbell from the Howard Hughes Medical Institute Iowa City for the generous gift of the antibodies to alpha-dystroglycan. We thank Marieke Lammers, MD for technical support.
###end p 48
###begin title 49
References
###end title 49
###begin article-title 50
Cell biology of the glomerular podocyte.
###end article-title 50
###begin article-title 51
Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix.
###end article-title 51
###begin article-title 52
###xml 63 71 <span type="species:ncbi:9606">patients</span>
Characterization of dystrophin in muscle-biopsy specimens from patients with Duchenne's or Becker's muscular dystrophy.
###end article-title 52
###begin article-title 53
Non-muscle alpha-dystroglycan is involved in epithelial development.
###end article-title 53
###begin article-title 54
###xml 45 50 <span type="species:ncbi:10090">mouse</span>
Distribution of dystroglycan in normal adult mouse tissues.
###end article-title 54
###begin article-title 55
Expression of agrin, dystroglycan, and utrophin in normal renal tissue and in experimental glomerulopathies.
###end article-title 55
###begin article-title 56
Localization of alpha-dystroglycan on the podocyte: from top to toe.
###end article-title 56
###begin article-title 57
A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin.
###end article-title 57
###begin article-title 58
Glomerular expression of dystroglycans is reduced in minimal change nephrosis but not in focal segmental glomerulosclerosis.
###end article-title 58
###begin article-title 59
Reactive oxygen species deglycosilate glomerular alpha-dystroglycan.
###end article-title 59
###begin article-title 60
The small leucine-rich repeat proteoglycan biglycan binds to alpha- dystroglycan and is upregulated in dystrophic muscle.
###end article-title 60
###begin article-title 61
###xml 36 41 <span type="species:ncbi:9606">human</span>
Small proteoglycans of normal adult human kidney: distinct expression patterns of decorin, biglycan, fibromodulin, and lumican.
###end article-title 61
###begin article-title 62
###xml 56 61 <span type="species:ncbi:9606">human</span>
Expression of decorin, biglycan, and collagen type I in human renal fibrosing disease.
###end article-title 62
###begin article-title 63
###xml 98 103 <span type="species:ncbi:9606">human</span>
An ultrastructural study of the colocalization of biglycan and decorin with AA amyloid fibrils in human renal glomeruli.
###end article-title 63
###begin article-title 64
Glomerular expression of biglycan and decorin and urinary levels of decorin in primary glomerular disease.
###end article-title 64
###begin article-title 65
###xml 23 28 <span type="species:ncbi:9606">human</span>
Small proteoglycans in human diabetic nephropathy: discrepancy between glomerular expression and protein accumulation of decorin, biglycan, lumican, and fibromodulin.
###end article-title 65
###begin article-title 66
Elevated expression of transforming growth factor-beta and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix.
###end article-title 66
###begin article-title 67
Podocyte proteoglycan synthesis is involved in the development of nephrotic syndrome.
###end article-title 67
###begin article-title 68
Glucocorticoid regulation of proteoglycan synthesis in mesangial cells.
###end article-title 68
###begin article-title 69
N-terminal alpha-dystroglycan binds to different extracellular matrix molecules expressed in regenerating peripheral nerves in a protein-mediated manner and promotes neurite extension of PC12 cells.
###end article-title 69
###begin article-title 70
###xml 138 142 <span type="species:ncbi:10116">rats</span>
Alterations in the distribution of plasma fibronectin and the ultrastructure of podocytes in the peripheral glomerular loops in nephrotic rats.
###end article-title 70
###begin article-title 71
###xml 135 140 <span type="species:ncbi:10090">mouse</span>
Deletion of protein kinase C-beta isoform in vivo reduces renal hypertrophy but not albuminuria in the streptozotocin-induced diabetic mouse model.
###end article-title 71
###begin article-title 72
###xml 54 58 <span type="species:ncbi:10090">mice</span>
Renoprotective effect of COMP-angiopoietin-1 in db/db mice with type 2 diabetes.
###end article-title 72
###begin article-title 73
Inhibiting albumin glycation attenuates dysregulation of VEGFR-1 and collagen IV subchain production and the development of renal insufficiency.
###end article-title 73
###begin article-title 74
Urinary and serum type III collagen: markers of renal fibrosis.
###end article-title 74
###begin article-title 75
Urine activity of cathepsin B, collagenase and urine excretion of TGF-beta 1 and fibronectin in membranous glomerulonephritis.
###end article-title 75
###begin article-title 76
###xml 98 106 <span type="species:ncbi:9606">children</span>
Analysis of collagen IV and fibronectin in blood and urine in evaluation of nephrotic fibrosis in children with chronic glomerulonephritis.
###end article-title 76
###begin article-title 77
Identification and characterization of the dystrophin anchoring site on beta-dystroglycan.
###end article-title 77
###begin article-title 78
The WW domain of dystrophin requires EF-hands region to interact with beta-dystroglycan.
###end article-title 78
###begin article-title 79
Adhesion-dependent tyrosine phosphorylation of (beta)-dystroglycan regulates its interaction with utrophin.
###end article-title 79
###begin article-title 80
WW and SH3 domains, two different scaffolds to recognize proline-rich ligands.
###end article-title 80
###begin article-title 81
Structure of a WW domain containing fragment of dystrophin in complex with beta-dystroglycan.
###end article-title 81
###begin article-title 82
The interaction of dystrophin with beta-dystroglycan is regulated by tyrosine phosphorylation.
###end article-title 82
###begin article-title 83
Tyrosine phosphorylation of beta-dystroglycan at its WW domain binding motif, PPxY, recruits SH2 domain containing proteins.
###end article-title 83
###begin article-title 84
SH3 domain-mediated interaction of dystroglycan and Grb2.
###end article-title 84
###begin article-title 85
A role of dystroglycan in schwannoma cell adhesion to laminin.
###end article-title 85
###begin article-title 86
Localization of phospho-beta-dystroglycan (pY892) to an intracellular vesicular compartment in cultured cells and skeletal muscle fibers in vivo.
###end article-title 86
###begin article-title 87
###xml 131 136 <span type="species:ncbi:10090">mouse</span>
Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines.
###end article-title 87
###begin article-title 88
Calcium signalling: dynamics, homeostasis and remodelling.
###end article-title 88
###begin article-title 89
Alternative splicing of agrin alters its binding to heparin, dystroglycan, and the putative agrin receptor.
###end article-title 89
###begin article-title 90
Structure of the C-terminal laminin G-like domain pair of the laminin alpha2 chain harbouring binding sites for alpha-dystroglycan and heparin.
###end article-title 90
###begin article-title 91
Structure and function of laminin LG modules.
###end article-title 91
###begin article-title 92
Integrin-linked kinase in renal disease: connecting cell-matrix interaction to the cytoskeleton.
###end article-title 92
###begin article-title 93
Regulation of adhesive interaction between podocytes and glomerular basement membrane.
###end article-title 93
###begin article-title 94
Caveolin-3 directly interacts with the C-terminal tail of beta -dystroglycan. Identification of a central WW-like domain within caveolin family members.
###end article-title 94
###begin article-title 95
###xml 54 60 <span type="species:ncbi:9913">bovine</span>
Association of the dystroglycan complex isolated from bovine brain synaptosomes with proteins involved in signal transduction.
###end article-title 95
###begin article-title 96
Src-family kinases stabilize the neuromuscular synapse in vivo via protein interactions, phosphorylation, and cytoskeletal linkage of acetylcholine receptors.
###end article-title 96
###begin article-title 97
Ezrin-dependent regulation of the actin cytoskeleton by beta-dystroglycan.
###end article-title 97
###begin article-title 98
Opposing roles of integrin alpha6-beta1 and dystroglycan in laminin-mediated extracellular signal-regulated kinase activation.
###end article-title 98
###begin article-title 99
Dystroglycan, a scaffold for the ERK-MAP kinase cascade.
###end article-title 99
###begin article-title 100
Genetic modifier screens reveal new components that interact with the Drosophila dystroglycan-dystrophin complex.
###end article-title 100
###begin article-title 101
Cultured podocytes establish a size-selective barrier regulated by specific signaling pathways and demonstrate synchronized barrier assembly in a calcium switch model of junction formation.
###end article-title 101
###begin article-title 102
TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function.
###end article-title 102
###begin article-title 103
A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis.
###end article-title 103
###begin article-title 104
Loss of glomerular foot processes is associated with uncoupling of podocalyxin from the actin cytoskeleton.
###end article-title 104
###begin article-title 105
Polycations induce calcium signaling in glomerular podocytes.
###end article-title 105
###begin article-title 106
Podocyte flattening and disorder of glomerular basement membrane are associated with splitting of dystroglycan-matrix interaction.
###end article-title 106
###begin article-title 107
Synaptopodin protects against proteinuria by disrupting Cdc42:IRSp53:Mena signaling complexes in kidney podocytes.
###end article-title 107
###begin article-title 108
Dystrophin-glycoprotein complex is highly enriched in isolated skeletal muscle sarcolemma.
###end article-title 108
###begin article-title 109
Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies.
###end article-title 109
###begin article-title 110
Measurement of cell numbers by means of the endogenous enzyme hexosaminidase. Applications to detection of lymphokines and cell surface antigens.
###end article-title 110
###begin article-title 111
###xml 107 112 <span type="species:ncbi:9606">human</span>
Inhibition of mitochondrial Na+-Ca2+ exchange restores agonist-induced ATP production and Ca2+ handling in human complex I deficiency.
###end article-title 111
###begin article-title 112
###xml 67 83 <span type="species:ncbi:10665">bacteriophage T4</span>
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
###end article-title 112
###begin article-title 113
Inclusion of phosphatase inhibitors during Western blotting enhances signal detection with phospho-specific antibodies.
###end article-title 113
###begin article-title 114
Synaptopodin orchestrates actin organization and cell motility via regulation of RhoA signalling.
###end article-title 114
###begin p 115
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 115
###begin p 116
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: The Dutch Kidney Foundation is gratefully acknowledged for their financial support (grants C.99.1832 and C.03.2067). The Dutch Kidney Foundation had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 116

